SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Boyce WJ, Vessey MP 1985 Rising incidence of fracture of the proximal femur. Lancet 8421: 150151.
  • 2
    Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Jarvinen M 1999 Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 353: 802805.
  • 3
    Spector TD, Cooper C, Lewis AF 1990 Trends in admission for hip fracture in England and Wales, 1968–85. BMJ 300: 11731174.
  • 4
    Falch JA, Kaastad TS, Bohler G, Espeland J, Sundsvold OJ 1992 Secular increases in geographical differences in hip fracture incidence in Norway. Bone 14: 643645.
  • 5
    Evans JG, Seagrott V, Goldacre MJ 1997 Secular trends in proximal femoral fracture, Oxford record linkage study area and England 1968–86. J Epidemiol Community Health 51: 424429.
  • 6
    Hedlund R, Lindgren U, Ahlbom A 1987 Age- and sex-specific incidence of femoral neck and trochanteric fracture: An analysis based on 20,538 fractures in Stockholm County, Sweden, 1972–1981. Clin Orthop 222: 132139.
  • 7
    Lau EMC, Cooper C, Fund H, Lam D, Tsang KK 1999 Hip fracture in Hong Kong over the last decade—a comparison with the UK. J Public Hlth Med 21: 249250.
  • 8
    Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M 1996 Epidemiology of hip fractures. Bone 18 (1 Suppl): 57S63S.
  • 9
    Gullberg B, Johnell O, Kanis JA 1997 World-wide projections for hip fracture. Osteopor Int 7: 407413.
  • 10
    Papadimitropoulos EA, Coyte PC, Josse RG, Greenwood CE 1997 Current and projected rates of hip fracture in Canada. Can Med Assoc J 157: 13571363.
  • 11
    Jaglal SB, Sherry PG, Schatzker J 1996 The impact of hip fracture in Ontario and its consequences. Can J Surg 2: 105111.
  • 12
    Brown JP, Josse RG for the Scientific Advisory Council of the Osteoporosis Society of Canada 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 167 (10 suppl): S1S34.
  • 13
    National Institute of Health 2001 Osteoporosis prevention, diagnosis and therapy. JAMA 285: 785795.
  • 14
    Osteoporosis Society of Canada 1996 Clinical practice guidelines for the diagnosis and management of osteoporosis. Can Med Assoc J 155: 11131129.
  • 15
    National Osteoporosis Foundation 1998 Physician's guide to prevention and treatment of osteoporosis. Available online at http://www.nof.org. Accessed July 14, 2004.
  • 16
    Pols HA, Felsenberg D, Hanley DA, Stepan J, Munoz-Torres M, Wilkin TJ, Qin-sheng G, Galich AM, Vandormael K, Yates AJ, Stych B 1999 Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study. Osteoporos Int 9: 461468.
  • 17
    Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH III, Brown JB, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD for the Vertebral Efficacy with Risedronate Therapy Study Group 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282: 13441352.
  • 18
    Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11: 8391.
  • 19
    Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. JAMA 282: 637645.
  • 20
    Jaglal SB, McIsaac W, Hawker G, Jaakkimainen L, Cadarette SM, Chan B 2000 Patterns of use of bone density testing in Ontario. Can Med Assoc J 16: 11391143.
  • 21
    Wallace LS, Ballard JE 2002 Osteoporosis coverage in selected women's magazines and newspapers, 1998–2001. J Bone Miner Res 17: S1: S359.
  • 22
    Chang KP, Center JR, Nguyen TV, Eisman JA 2004 Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 19: 532536.
  • 23
    Lofman O, Berglund K, Larsson L, Toss G 2002 Changes in hip fracture epidemiology: Redistribution between ages, genders and fracture types. Osteoporos Int 13: 1825.
  • 24
    Gullberg B, Huppe H, Nilsson B, Redlund-Johnell I, Sernbo I, Obrant K, Johnell O 1993 Incidence of hip fractures in Malmo, Sweden (1950–1991). Bone 14: S23S29.
  • 25
    Falch JA, Aho H, Berglund K, Duppe H, Finsen V, Hagstrom I, Jarvinen M, Johnell O, Kaastad TS, Lauritzen JB, Lund B, Luthje P, Lofman O, Mellstrom D, Mowinckel P, Rossvoll I, Sernbo I, Witso E, Zetterberg C 1995 Hip fractures in Nordic cities: Difference in incidence. Ann Chir Gynaecol 84: 286290.
  • 26
    Sernbo I, Gullberg B, Johnell O 1993 Hip fracture in Malmo over three decades. Bone 14: S19S22.
  • 27
    van Staa TP, Dennison EM, Leufkens HGM, Cooper C 2001 Epidemiology of fractures in England and Wales. Bone 29: 517522.
  • 28
    Ontario Health Insurance Plan 1999 Schedule of Benefits. Bulletin on Bone Density Testing. Ontario Ministry of Health and Long-Term Care, Toronto, Canada.
  • 29
    Ontario Ministry of Health 2004 Ontario Drug Benefit Formulary/Comparative Drug Index. Available online at http://www.health.gov.on.ca/english/providers/program/drug/formulary/limited_use_062304.pdf. Accessed on August 5, 2004.
  • 30
    Ray WA, Griffin MR, West R, Strand L, Melton LJ III 1990 Incidence of hip fracture in Saskatchewan, Canada 1976–1985. Am J Epidemiol 131: 502509.
  • 31
    Pindyck RS, Rubinfeld DL 1998 Econometric Models and Economic Forecasts, 4th ed. Irwin McGraw-Hill, New York, NY, USA.
  • 32
    Dickey DA, Fuller WA 1979 Distribution of the estimators for autoregressive time series with a unit root. J Am Stat Assoc 74: 427431.
  • 33
    Ljung GM, Box GEP 1978 On a measure of lack of fit in time series models. Biometrika 65: 297303.
  • 34
    Rubin SM, Cummings SR 1992 Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 116: 990995.
  • 35
    Ryan PJ, Harrison R, Blake GM, Fogelman I 1992 Compliance with hormone replacement therapy after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 99: 325328.
  • 36
    Phillipov G, Mos E, Scinto S, Phillips PJ 1997 Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry. Osteoporos Int 7: 162164.
  • 37
    Silverman SL, Greenwald M, Klein RA, Drinkwater B 1997 Effect of bone density information on decisions about hormone replacement therapy: A randomized trial. Obstet Gynecol 89: 321325.
  • 38
    Papaionannou A, Parkinson W, Adachi J, O'Connor A, Jolly EE, Tugwell P, Bedard M 1998 Women's decisions about hormone replacement therapy after education and bone densitometry. Can Med Assoc J 159: 12531257.
  • 39
    Marci CD, Viechnicki MB, Greenspan SL 2000 Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int 66: 113118.
  • 40
    Fitt NS, Mitchell SL, Cranny A, Gulenchyn K, Huang M, Tugwell P 2001 Influence of bone densitometry results on the treatment of osteoporosis. Can Med Assoc J 164: 777781.
  • 41
    McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY 2001 Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344: 333340.
  • 42
    Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Randomised drial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348: 15351541.
  • 43
    Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC, Camos Research Group 2000 Estimation of the prevelence of low bone density in Canadian women and men using a population-specific DXA reference standard. The Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11: 897904.
  • 44
    Hodsman AB, Hanley DA, Josse R 2002 Do bisphosphonates reduce the risk of osteoporotic fractures. An evaluation of the evidence to date. Can Med Assoc J 166: 14261430.
  • 45
    Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M 2000 Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis. J Bone Miner Res 15: 721739.
  • 46
    Cuddihy MT, Gabriel SE, Crowson CS, O'Fallon WM, Melton LJ 1999 Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int 9: 469475.
  • 47
    Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo U-B, Bergstrom R 1993 Fracture of the distal orearm as a forecaster of subsequent hip fracture: A population-based cohort study with 24 years of follow-up. Calcif Tissue Int 52: 269272.
  • 48
    Lauritzen JB, Schwarz P, McNair P, Lund B, Transbol I 1993 Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation. Osteoporos Int 3: 133137.
  • 49
    Wiktorowicz M, Goeree R, Papaioannou A, Adachi J, Papadimitropoulos EA 2001 Economic implications of hip fracture: Health service use, institutional care and cost in Canada. Osteoporos Int 12: 271278.
  • 50
    Greenspan SL 1999 A 73-year-old woman with osteoporosis. JAMA 281: 15311540.
  • 51
    Feldstein AC, Nichols GA, Elmer PJ, Smith DH, Aickin M, Herson M 2003 Older women with fractures: Patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Jt Surg Am 85: 22942302.
  • 52
    Feldstein AC, Elmer PJ, Orwoll E, Herson M, Hillier T 2003 Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures. Arch Intern Med 163: 21652172.
  • 53
    Hajcsar EE, Hawker G, Bogoch ER 2000 Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 163: 819822.
  • 54
    Khan SA, DeGeus C, Holroyd B, Russell AS 2000 Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med 161: 13091312.
  • 55
    Cuddihy MT, Gabriel SE, Sherine E, Crowson CS, Atkinson EJ, Tabini C, O'Fallon WM, Melton L 2002 Osteoporosis intervention following distal forearm fractures: A missed opportunity? Arch Intern Med 162: 421426.
  • 56
    Juby AG, De Geus-Wenceslau CM 2002 Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 13: 205210.
  • 57
    Kamel HK, Hussain MS, Tariq S, Perry HM III, Morley JE 2000 Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 109: 326328.
  • 58
    Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA 2000 Treatment of osteoporosis: Are physicians missing an opportunity? J Bone Joint Surg Am 82: 10631070.
  • 59
    Gallagher TC, Geling O, Comite F 2002 Missed opportunities for prevention of osteoporotic fracture. Arch Intern Med 162: 450456.
  • 60
    Simonelli C, Chen YT, Morancey J, Lewis AF, Abbott TA 2003 Evaluation and management of osteoporosis following hospitalization for low-impact fracture. J Gen Intern Med 18: 1722.
  • 61
    Torgerson DJ, Dolan P 1998 Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 57: 378379.